SULT2A1 catalyzes the sulfate conjugation of dehydroepiandrosterone (DHEA) as well as other steroids. As a step toward pharmacogenetic studies, we have 'resequenced' SULT2A1 using 60 DNA samples from African-American and 60 samples from Caucasian-American subjects. All exons, splice junctions and approximately 370 bp located 5Ј of the site of transcription initiation were sequenced. We observed 15 single nucleotide polymorphisms (SNPs), including three non-synonymous coding SNPs (cSNPs) that were present only in DNA from African-American subjects. Linkage analysis revealed that two of the nonsynonymous cSNPs were tightly linked. Expression constructs were created for all nonsynonymous cSNPs observed, including a 'double variant' construct that included the two linked cSNPs, and those constructs were expressed in COS-1 cells. SULT2A1 activity was significantly decreased for three of the four variant allozymes. Western blot analysis demonstrated that decreased levels of immunoreactive protein appeared to be the major mechanism responsible for decreases in activity, although apparent K m values also varied among the recombinant allozymes. In addition, the most common of the nonsynonymous cSNPs disrupted the portion of SULT2A1 involved with dimerization, and this variant allozyme behaved as a monomer rather than a dimer during gel filtration chromatography. These observations indicate that common genetic polymorphisms for SULT2A1 can result in reductions in levels of both activity and enzyme protein. They also raise the possibility of ethnic-specific pharmacogenetic variation in SULT2A1-catalyzed sulfation of both endogenous and exogenous substrates for this phase II drug-metabolizing enzyme.
INTRODUCTION
Sulfate conjugation is an important pathway in the biotransformation of many drugs, other xenobiotics, neurotransmitters and hormones-especially steroid hormones.
1,2 Sulfation or, more accurately, sulfonation of these compounds is catalyzed by cytosolic sulfotransferase (SULT) enzymes that usually exist as homodimers.
2 SULT2A1 is a member of this family of enzymes. It catalyzes the sulfate conjugation of dehydroepiandrosterone (DHEA) and other structurallyrelated steroids (Figure 1 ) 3, 4 and has been reported to contribute to the metabolic activation of procarcinogens. 5, 6 SULT2A1 is highly expressed in the human liver, small intestine and adrenal cortex. 7, 8 Therefore, orally administered substrates would undergo sulfate conjugation catalyzed by SULT2A1. In addition, circulating endogenous levels of DHEA sulfate decrease with increasing age 9 and are influenced by inheritance. 10 In the United States, DHEA is marketed over-the- counter in health food stores as a dietary supplement 'to counter the effects of aging'. 11, 12 Pharmacogenetic variation in SULT2A1 activity could, therefore, influence the biotransformation of both orally administered agents and/or endogenous substrates.
Several years ago we set out to study SULT2A1 pharmacogenetics. As a first step, we demonstrated the presence of large individual variations in human liver 'DHEA sulfotransferase' activity-an activity catalyzed primarily by SULT2A1. 13 Subsequently, we cloned the cDNA and gene that encode human SULT2A1. 7, 14 The human gene was approximately 17 kb in length, consisted of six exons and mapped to chromosome 19q13.3. [14] [15] [16] [17] In the present experiments, we have used a genotype-to-phenotype strategy to test the hypothesis that SULT2A1, like other genes encoding human SULT enzymes, [18] [19] [20] might contain common, functionally significant genetic polymorphisms. Specifically, we resequenced SULT2A1 using DNA from 60 Caucasian-American and 60 African-American subjects and observed 15 polymorphisms, including three novel cSNPs that altered the encoded amino acid-all three of which were present only in DNA from African-American subjects. Expression constructs were created for all of these nonsynonymous cSNPs, including one double variant allele, followed by functional genomic studies of the encoded recombinant allozymes. Three of the four variant allozymes displayed significant decreases in level of activity as compared with the wild-type enzyme and one of them altered the ability of the enzyme to dimerize. These results raise the possibility of ethnic-specific pharmacogenetic variation in sulfate conjugation catalyzed by SULT2A1.
RESULTS

SULT2A1 Resequencing
SULT2A1 was resequenced by performing seven PCR reactions for each of the 120 DNA samples studied. A total of over 600 000 bp of DNA sequence was analyzed, and 98.7% of that DNA was sequenced on both strands. Dye primer sequencing chemistry was used to enhance the detection of heterozygous nucleotides. 21 These data were compared to the SULT2A1 sequence deposited in GenBank at the time that the gene was originally cloned and characterized (accession numbers U13056-U13061).
14 Fifteen SNPs were observed in the 120 DNA samples (240 alleles) studied www.nature.com/tpj ( Figure 2 and Table 1 ). DNA samples from African-American subjects contained 14 SNPs, and DNA from CaucasianAmerican subjects contained six SNPs-only one of which was not also present in DNA from African-American subjects. No insertion-deletion events were observed within the area resequenced. Ten of the 14 SNPs in African-American and all six of the SNPs in DNA from Caucasian-American subjects had frequencies of greater than 1% and would, therefore, be considered 'common' in these populations. SNPs seen in only a single sample were verified by performing a separate, independent amplification, followed by DNA sequencing. We observed three nonsynonymous cSNPs, all of which were present only in DNA from AfricanAmerican subjects. The nonsynonymous cSNPs were G187C, A679G and G781A, which changed amino acids Ala63Pro, Lys227Glu and Ala261Thr, respectively. Only one SNP was observed in the 5Ј-flanking region at position (Ϫ122). That SNP had an allele frequency of 0.042 in the African-American subjects and was located in a putative AP1 binding site, but the polymorphism did not disrupt the AP1 recognition motif. Nucleotide positions for all SNPs were numbered with respect to the 'A' in the ATG translation initiation codon. Positions 5Ј to that location were assigned negative, and positions 3Ј were assigned positive numbers. A search of publicly accessible DNA sequence databases, including the EST database (www.ncbi.nlm.nih.gov/dbEST), dbSNP (www.ncbi.nlm.nih.gov/SNP), public Human Genome Project sequence and all available SNP databases listed in a recent summary, 22 showed that none of the SNPs that we had observed were present in public databases. The SULT2A1 SNPs which were listed in those databases were located in portions of the gene-eg, introns-that we had Frequencies for each variant allele in the two population samples studied are listed. '5Ј-FR' represents the 5Ј-flanking region of the gene, and 'I' indicates intron. The numbering scheme for nucleotides located in exons and in the 5Ј-flanking region was based on the cDNA sequence, with the 'A' in the translation initiation codon designated ϩ1. Positions 5Ј to that location were assigned negative numbers, while those 3Ј to that position were assigned positive numbers. Intron-based primers were numbered on the basis of nucleotide distance from splice junctions, with ϩ1 designated as the first nucleotide at the 5Ј-end of an intron, while (Ϫ1) was the first nucleotide at the 3Ј-end of an intron.
not resequenced. Finally, in a recently published study from Japan, a series of SULT enzymes were resequenced using DNA from 48 healthy Japanese subjects. The SULT2A1 data included nine SNPs that were located in introns within areas of the gene that we did not resequence in our experiments, but none of the 15 SNPs that we observed in African-American and Caucasian-American subjects were present in these DNA samples from Japanese subjects. 23 It has been suggested that haplotype may ultimately prove to be at least as important for understanding function as the analysis of individual polymorphisms. 24 Therefore, we also performed linkage analysis for all SULT2A1 SNPs that were observed more than once. Specifically, DЈ values were calculated for all pairwise combinations of SNPs. DЈ values can range from ϩ1.0 when two polymorphisms are maximally positively associated, to Ϫ1.0 when two polymorphisms never occur together. 25, 26 Only seven pairs of SNPs had statistically significant Chi-square values (Ͼ3.84) for DЈ, and only the three polymorphisms at nucleotides (Ϫ122), 187 and 781 had absolute DЈ values which were greater than 0.3. In all three of those cases, DЈ was 1.0-ie, all three of these SNPs were highly linked, even though one was located in the 5Ј-flanking region, one was in exon 2 and the final SNP was in exon 6. That is, they were spread over a total length of approximately 14.7 kb. These results were of special interest because the SNPs at nucleotides 187 and 781 were nonsynonymous-with frequencies in DNA samples from African-American subjects of 0.05 and 0.137, respectively.
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Therefore, one common haplotype in samples from AfricanAmerican DNA subjects included all three of these SNPs. That fact was of practical importance when expression constructs were created to study the functional implications of SULT2A1 cSNPs.
Recombinant Allozyme Enzyme Activity
Our functional genomic studies focussed on SULT2A1 alleles that contained nonsynonymous cSNPs. Specifically, expression constructs that encoded each of the three SULT2A1 variant amino acid sequences, as well as the double variant at codons 63 and 261 (SNPs at ORF nucleotides 187 and 781), were expressed in COS-1 cells. A mammalian expression system was used to ensure appropriate posttranslational modification as well as the presence of mammalian protein degradation systems. There have now been several reports of situations in which the change of a single amino acid has resulted in significant decreases in levels of immunoreactive protein-due in some cases to alterations in proteosome-mediated protein degradation. 20, [27] [28] [29] Three of the four recombinant SULT2A1 allozymes had significantly decreased enzyme activity, after correction for transfection efficiency, as compared to that of the 'wild-type' sequence ( Figure 3a and Table 2 ). The values shown graphically in Figure 3a are averages of those observed during six independent transfections. Transfection with the construct that contained the Ala63Pro change in sequence, a polymorphism with a frequency of 0.05 in African-American sub- jects, resulted in only 57% of the average activity present after transfection with the wild-type sequence. When the Ala63Pro polymorphism was combined with Ala261Thr, thus creating the double variant that occurred commonly in the African-American subjects studied, enzyme activity was decreased to 42% of the wild-type level ( Figure 3a and Table  2 ). However, activity of the Ala261Thr variant alone-an allozyme encoded by approximately 8% of all alleles in African-American subjects-did not differ significantly from that of the wild-type enzyme. The Lys227Glu polymorphism, with a frequency of 0.008 in DNA samples from African-Americans, resulted in the largest decrease in activity. Lysates from COS-1 cells transfected with that construct had only 15% of the wild-type activity ( Figure 3a and Table 2 ). The next step in this series of experiments involved studies of mechanisms responsible for differences in levels of activity among these recombinant SULT2A1 allozymes.
Recombinant Allozyme Substrate Kinetics
One way in which a change in amino acid sequence can affect enzyme activity is by an alteration of kinetic properties. Therefore, we determined apparent K m values for both DHEA and the sulfate donor cosubstrate, 3Ј-phosphoadenosine 5Ј-phosphosulfate (PAPS), for all of the recombinant SULT2A1 allozymes. Because SULTs, including SULT2A1, can show profound substrate inhibition, 1 experiments involving the sulfate acceptor cosubstrate were conducted in two stages. Initially, a wide range of concentrations was tested-followed by a determination of K m values within a narrower range of concentrations. Although there were statistically significant variations among the allozymes in apparent K m values for both DHEA and PAPS, those variations were not large quantitatively and-in the case of PAPS-the apparent K m values for three of the variant allozymes were significantly lower than that of the wild-type enzyme ( Table 2) . As a result, decreases in level of enzyme activity observed for three of the four variant allozymes could not be attributed entirely to alterations in substrate affinity. Therefore, our next experiments involved an attempt to determine whether decreases in activity might be due to alterations in levels of SULT2A1 immunoreactive protein.
Recombinant Allozyme Western Blot Analysis
Quantitative Western blot analysis showed that levels of immunoreactive SULT2A1, corrected for transfection efficiency, paralleled relative levels of enzyme activity among the variant allozymes (Table 2) . Western blot analysis data were obtained by assaying cytosol for each allozyme from three independent transfections performed on different days to ensure that results were reproducible. The data listed in Table 2 are averages of those three transfections. The table also lists the ratio of enzymatic activity to immunoreactive protein for each allozyme. A representative Western blot gel is shown in Figure 3b . It should be noted that none of the alterations in encoded amino acid for the variant allozymes studied were located within the sequence of the peptide used to generate the rabbit polyclonal antibody utilized to perform the Western blots. 30 These studies showed that alterations in the amino acid sequence of SULT2A1 as a result of genetic polymorphisms, as has been reported for other proteins, 20, 27, 28 significantly altered levels of enzyme protein.
SULT2A1 Crystal Structure and Dimerization
The x-ray crystal structure of SULT2A1 has been solved at a resolution of 2.3 Å. 31 As a result, we were able to determine the locations of polymorphic SULT2A1 amino acids within that structure. The polymorphism that resulted in the Ala63Pro change in amino acid was located 14 residues downstream from the conserved 'Region I' sequence motif that is present in all known human SULTs and which is thought to be involved in PAPS binding. 1, 32, 33 That change in amino acid resulted in a 43% decrease in enzyme activity as well as a decrease in immunoreactive protein (Table 2 ). This amino acid was located on the 'surface' of the protein. Lys227Glu was located four amino acids upstream of the putative SULT2A1 substrate binding site. 31 Like Ala63Pro, this residue was also on the surface of the protein. This latter alteration in sequence resulted in a striking decrease in enzyme activity (to 15% of the activity of the wild-type sequence) as well as a very low level of immunoreactive protein (Table 2) .
Of interest was the fact that the Ala261Thr polymorphism, present in 13.3% of the African-American population sample studied, was located within the dimerization motif found at the C-terminus of the conserved 'Region IV' SULT signature sequence. 34 Therefore, the possibility arose that this polymorphism might alter the formation of the SULT2A1 homodimer. To test that hypothesis, we subjected recombinant wild-type and codon Thr261 variant allozyme preparations to gel filtration chromatography through Sephadex G-100. Those experiments showed that the major peak for wild-type enzyme was compatible with the presence of SULT2A1 dimer, while that for the variant allozyme was compatible with monomer ( Figure 4) . As a result, this appears to be the first demonstration of a common SULT genetic polymorphism that disrupts dimerization-with functional consequences that are presently unknown.
DISCUSSION
Sulfate conjugation is an important pathway in the biotransformation of both exogenous and endogenous compounds.
1,2 Human SULT2A1 catalyzes the sulfate conjugation of DHEA and other structurally-related steroids, and
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3,5-7 Sulfation is the major metabolic pathway for the metabolism of DHEA in humans, 9 just as it is for many other endogenous and exogenous steroids. 35 Circulating levels of DHEA sulfate vary widely among individuals, decrease with age and are known to be influenced by inheritance.
9,10 All of those observations made SULT2A1 an attractive candidate for pharmacogenetic studies.
The present experiments were initiated to determine whether common SULT2A1 genetic polymorphisms might exist, whether they might vary among ethnic groups and, if so, to determine whether they might be of functional significance. We applied a genotype-to-phenotype strategy that began with the resequencing of SULT2A1, including all exons, portions of introns flanking exons and the 5Ј-flanking region of the gene-using DNA samples from AfricanAmerican and Caucasian-American subjects. Fifteen SNPs, including three non-synonymous cSNPs, were observed in the 120 DNA samples (240 alleles) resequenced. The DNA samples from African-American subjects had more than twice as many SNPs within the area resequenced as did samples from Caucasian-American subjects, and all three of the non-synonymous cSNPs were observed only in DNA from African-American subjects. These observations are similar to those obtained during other resequencing efforts which have demonstrated greater DNA sequence variation in samples from African subjects than in those from European-Caucasian subjects-even within areas of DNA that contained no genes and, thus, were thought to be less likely to be influenced by natural selection. 36 The majority of the SULT2A1 SNPs, both in samples from Caucasian-American and African-American subjects, were present at frequencies greater than 0.01 (1%), and none were available in public DNA sequence databases. However, it was puzzling that we failed to observe either of the two cSNPs reported during a previous study of DNA from Caucasian subjects 30 that was performed prior to a time when automated sequencing was widely available and prior to the development of sophisticated DNA sequence analysis software such as PolyPhred and Consed.
We also studied recombinant allozymes for each of the SULT2A1 SNPs that altered amino acid sequence as well as the common double variant allozyme that occurs in AfricanAmerican subjects. After expression in COS-1 cells, three of the four variant sequences resulted in both decreased enzyme activity and decreased levels of immunoreactive protein, although the extent of those decreases differed among the polymorphisms studied (Table 2 and Figure 3 ). Apparent K m values for PAPS and DHEA, the two cosubstrates for the reaction, also differed significantly when variant recombinant allozymes were compared with the wildtype enzyme. However, those differences were smaller than were variations in protein quantity (Table 2 ). These observations indicate that-for SULT2A1-mechanisms by which changes in encoded amino acids decrease enzyme activity involve both alterations in quantity of enzyme protein and alterations in substrate kinetic parameters. There is increasing evidence that changes of single amino acids as a result of genetic polymorphisms often result in decreased levels of protein. 20, 27, 28 Those decreases could result from a series of mechanisms-including variations in transcription, RNA splicing, mRNA stability, mRNA translation or protein degradation. In one case which has been studied in detail, that involving the genetically polymorphic drug-metabolizing enzyme thiopurine S-methyltransferase, the mechanism has been shown to involve an increased rate of proteosomemediated degradation. 29 A similar mechanism for decreased protein levels has been described for the most common cystic fibrosis transmembrane conductance regulator (CFTR) mutation, CFTR⌬F508. 37 All of these mechanisms should be explored systematically for the SULT2A1 genetic polymorphisms in the course of future experiments-experiments that should also address the possible functional implications of the 5Ј-flanking region SNP located at nucleotide (Ϫ122). Included among those functional studies should be a determination of the functional consequences-if any-of the disruption of the formation of the SULT2A1 dimer by the common codon 261 polymorphism (Figure 4) . Our results indicated that this common SNP disrupted the ability of the variant allozyme to dimerize. The full functional implications of that observation remain to be explored in the course of future experiments.
In summary, we set out to determine whether an important human sulfotransferase gene, SULT2A1, might display common genetic polymorphisms. Resequencing SULT2A1 in 120 DNA samples revealed 15 SNPs, many of which showed striking differences in frequency between the two ethnic groups studied (Table 1) . Functional genomic studies performed by transfecting COS-1 cells with constructs that encoded SULT2A1 variant allozymes showed sigwww.nature.com/tpj nificantly decreased activity for three of the four constructs ( Figure 3a and Table 2 ). Those decreases were due both to decreased levels of immunoreactive SULT2A1 protein and alterations in substrate kinetics ( Table 2 ). The next step in this series of genotype-to-phenotype studies will involve a determination of possible in vivo alterations in the pharmacokinetics and/or the effects of orally administered agents metabolized by this phase II drug-metabolizing enzyme as a result of these common SULT2A1 genetic polymorphisms.
MATERIALS AND METHODS
DNA Samples
DNA samples from 60 Caucasian-American and 60 AfricanAmerican subjects were obtained from the 100-item sample sets HD100CAU and HD100AA held by the Coriell Cell Repository (Camden, NJ, USA). These samples had been anonymized prior to their deposit in the Coriell Cell Repository. All subjects had provided written consent for the use of their DNA for experimental purposes, and the present studies were reviewed and approved by the Mayo Clinic Institutional Review Board.
DNA Sequencing
The PCR was used to amplify each of the six SULT2A1 exons, as well as approximately 370 bp of the 5Ј-flanking region of the gene. An M13 'tag' was added to the 5Ј-terminus of each primer to make it possible to use dye primer sequencing chemistry. Dye primer chemistry enhanced our ability to identify heterozygous sequence. 21 Primer locations were chosen to be SULT2A1-specific and to avoid repetitive sequence. Sequences for the primers used in these and subsequent experiments are listed in Table 3 . PCR amplifications were performed using 2.5 units of AmpliTaq Gold DNA polymerase (Perkin Elmer, Foster City, CA, USA), 0.5 l of DNA as supplied by the Coriell Cell Repository, 12.5 pmol of each primer, 0.25 mM dNTPs (Boehringer Mannheim, Indianapolis, IN, USA), and 5 l of 10ϫ buffer (Perkin Elmer) that contained 15 mM MgCl 2 in a final 50 l reaction volume. Reactions were initiated with a 12 min 'hot start' at 94°C, followed by 35 cycles at 94°C for 30 s, a primer-specific annealing temperature (see Table 3 ) for 30 s and 45 s at 72°C, with a final 10 min extension at 72°C. Reactions were performed in a Perkin Elmer model 9700 thermal cycler. Amplification products were sequenced in the Mayo Molecular Biology Core Facility with an ABI 377 DNA sequencer (Applied Biosystems) using Big Dye  (Perkin Elmer) dye primer chemistry. Samples were sequenced on both strands, and those with ambiguous sequencing chromatograms, as well as samples with SNPs that were observed in only a single sample, were subjected to a second, independent amplification, followed by DNA sequencing.
DNA sequence was analyzed using the PolyPhred 3.0 Exon 6 TTCAGCTTGGGTCACTGTGAAGT G781A
The underlined portions of primers used for the resequencing experiments are M13 tags that were added at the 5Ј-terminus to make it possible to use dye primer DNA sequencing chemistry. The underlined nucleotide in the sequences of primers used to perform site-directed mutagenesis is the 'mutated' base. 'F' represents forward; 'R', reserve; 'U', upstream; and 'I', intron. 'N/A' indicates 'not applicable'. The numbering scheme for nucleotide locations is described in the legend for Table 1 .
sequences against which the resequencing data were compared were those with GenBank accession numbers U13056-U13061.
SULT2A1 Expression Studies
Expression constructs for the wild-type SULT2A1 cDNA sequence construct, as well as constructs with the three nonsynonymous cSNPs that we observed and a construct containing two linked cSNPs, were created by site-directed mutagenesis using overlap extension. 40 The sequences of the primers which were used to create these constructs are listed in Table 3 . Inserts with the wild-type and mutated sequences were cloned into the expression vector pCR3.1 (Invitrogen, Carlsbad, CA, USA), and those expression constructs were used to transfect COS-1 cells using TransFast reagent (Promega, Madison, WI, USA) at a charge ratio of 1:1 in serum free Dulbecco's Modified Eagles Medium (DMEM) (Bio Whittaker, Walkersville, MD, USA) with a 2-h transfection time. Transfection was also performed with 'empty' vector, ie, pCR3.1 that lacked an insert, to make it possible to correct for endogenous COS-1 cell SULT activity. Seven g of construct DNA was co-transfected with 7 g of pSV-␤-Galactosidase DNA (Promega) to provide a control to make it possible to correct for transfection efficiency. After transfection, the COS-1 cells were incubated at 37°C for 48 h, washed with phosphate buffered saline (PBS) and resus-
The Pharmacogenomics Journal pended in 2 ml of 5 mM potassium phosphate buffer, pH 6.5. The cells were then lysed with a Polytron homogenizer (Brinkmann Instruments, Westbury, NY, USA), and homogenates were centrifuged at 100 000 ϫ g for 1 h. The resulting cytosol preparations were stored at Ϫ80°C prior to assay.
Enzyme Assays
Recombinant allozymes were assayed for SULT2A1 activity as described by Hernández et al 4 and Wood et al 30 using a modification of the method of Foldes and Meek. 41 Specifically, 5 M DHEA served as the sulfate acceptor cosubstrate and 0.4 M 35 S-PAPS was the sulfate donor. Blanks were samples that contained no sulfate acceptor substrate. Levels of enzyme activity were corrected for transfection efficiency by measuring ␤-galactosidase activity. Activity in cells transfected with empty vector was also assayed to determine endogenous SULT2A1-like activity and those values-which never exceeded 1% of the activity observed after transfection with the 'wild-type' construct-were subtracted from levels of activity in cells transfected with the expression constructs.
This same assay was used to determine apparent K m values for each of the two cosubstrates with each recombinant allozyme. Because SULTs display profound substrate inhibition, 1 K m values for DHEA were determined in a two-step process.
During the first step, DHEA concentrations that varied in 10-fold increments over a range from 100 nM to 1.0 mM were tested. After we determined that peak activity for all allozymes occurred near 1 M, assays were repeated in the presence of 0.4 M 35 S-PAPS using eight concentrations of DHEA that varied from 7.8 nM to 1.0 M. Apparent K m values for PAPS were determined in the presence of 5 M DHEA using six PAPS concentrations that varied from 3.13 nM to 100 nM. ␤-Galactosidase activity was measured spectrophotometrically with the ␤-Galactosidase Enzyme Assay System (Promega) as suggested by the manufacturer. All results were corrected for transfection efficiency.
Western Blot Analysis
Levels of immunoreactive SULT2A1 were determined for each recombinant allozyme by performing quantitative Western blot analysis. Rabbit polyclonal antibody directed against SULT2A1 amino acids 268-285, with an additional amino terminus cysteine (described in detail by Wood et al 30 ), at a dilution of 1:2000 was used to perform these studies. Specifically, recombinant protein was loaded on a 12% SDS mini-gel (BioRad, Hercules, CA, USA) in quantities that resulted in equal ␤-galactosidase activity, ie, loading was corrected for transfection efficiency. Electrophoresis was performed for 1 h at 150 volts, and proteins were transferred to nitrocellulose membranes. The membranes were then 'blocked' overnight at 4°C with 5% dried milk in Tris buffered saline with Tween-20 (TBST). Subsequently, they were incubated with primary antibody for 1 h, followed by three TBST washes. The secondary antibody was a 1:10 000 dilution of goat anti-rabbit horseradish peroxidase (BioRad) that was applied for 1 h in 5% milk in TBST, followed by multiple washes. Bound antibody was detected by enhanced chemiluminescence performed with the ECL Western Blotting System (Amersham Pharmacia, Piscataway, NJ, USA) as described previously. 42 Multiple blots were assayed for each allozyme, and immunoreactive protein levels were expressed as a percentage of the intensity of the wild-type construct on the same gel. Blots were analyzed with the AMBIS Radioanalytic Imaging System, Quant Probe v. 4.31 (AMBIS, San Diego, CA, USA).
Gel Filtration Chromatography
Gel filtration chromatography of recombinant human SULT2A1 was performed at 4°C with a 2 ϫ 25 cm column of Sephadex G-100 superfine. The mobile phase was 5 mM K phosphate buffer, pH 7.5, and 3 ml fractions were collected at a flow rate of approximately 1.8 ml per h. The fractions were then assayed for SULT2A1 activity. Standards for column calibration were eluted separately and included Dextran Blue 2000, bovine serum albumin (67 kDa), ovalbumin (45 kDa), chymotrypsinogen A (20 kDa) and ribonuclease A (13.7 kDa). 25, 26 DЈ is a method of linkage analysis that is independent of polymorphism frequency.
Data Analysis
